v3.23.2
NON-CONTROLLING INTEREST (Details Narrative) - $ / shares
 12 Months Ended
Dec. 31, 2022
Jun. 30, 2023
Jan. 02, 2023
Jun. 30, 2022
Dec. 31, 2021
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]          
Common stock, shares issued 123,252,235 132,035,294 123,252,235 0 110,840,998
Common stock, shares outstanding 123,252,235 132,035,294 123,252,235 0 110,840,998
Affiliate [Member]          
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]          
Options exercisable price $ 0.08849        
Stock issued during period shares exercise of options 16,782,189        
Stock issued during period shares cash les exercise of options 15,594,189        
Pharmalectin, Inc. [Member]          
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]          
Common stock, shares issued 30,000,000 30,000,000     30,000,000
Common stock, shares outstanding 19,650,000 19,650,000     19,650,000
Pharmalectin, Inc. [Member] | Parent Company [Member]          
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]          
Common stock, shares outstanding 15,000,000 15,000,000     15,000,000
Percentage of oustanding shares 76.00%        
Pharmalectin, Inc. [Member] | Affiliate [Member]          
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]          
Common stock, shares outstanding 4,650,000 4,650,000      
Options outstanding 4,500,000 4,500,000      
Options exercisable price $ 0.33